Skip to content
WeighLab

Freya Meds vs VyrarX

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Freya Meds

Provider comparison

Shoppers who want a GLP-1-only telehealth bundle with dietitian and group-call access included, and are willing to compare the quarterly vs. monthly rate.

Semaglutide / month
$297/moAll doses, monthly plan, compounded; $250/mo on a quarterly plan billed every 3 months
Tirzepatide / month
$390/moAll doses, monthly plan, compounded; $332/mo on a quarterly plan billed every 3 months
Index 70/100 · Grade CChecked October 2026

VyrarX

Provider comparison

Readers in a served state who will confirm the medication formulation, dose-specific price and refill cadence before paying.

Semaglutide / month
Formulation to confirm (semaglutide program from $179/mo)
Tirzepatide / month
Formulation to confirm (tirzepatide program from $329/mo)
Index 70/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 70/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Freya Meds
47 states
VyrarX
47 states; excludes California, South Carolina and New Jersey

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Freya Meds

VyrarX

Semaglutide / month
Freya Meds: $297/moAll doses, monthly plan, compounded; $250/mo on a quarterly plan billed every 3 months
VyrarX: Formulation to confirm (semaglutide program from $179/mo)
Tirzepatide / month
Freya Meds: $390/moAll doses, monthly plan, compounded; $332/mo on a quarterly plan billed every 3 months
VyrarX: Formulation to confirm (tirzepatide program from $329/mo)
Semaglutide / year (modeled)
Freya Meds: $3,564
VyrarX: —
Tirzepatide / year (modeled)
Freya Meds: $4,680
VyrarX: —
State availability
Freya Meds: 47 states
VyrarX: 47 states; excludes California, South Carolina and New Jersey
Oral / sublingual option listed
Freya Meds: Not listed
VyrarX: Not listed
Brand-name access listed
Freya Meds: Not confirmed
VyrarX: Not confirmed
Provider facts checked
Freya Meds: October 2026
VyrarX: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Freya Meds

Shoppers who want a GLP-1-only telehealth bundle with dietitian and group-call access included, and are willing to compare the quarterly vs. monthly rate.

Reasons to consider it

  • GLP-1 specialist, not a multi-category telehealth platform
  • Both quarterly ($250/$332) and monthly ($297/$390) rates are transparently published on the product pages themselves, cancel-anytime with no lock-in
  • Bundle includes unlimited doctor consultations, monthly group calls, and a dietitian consultation at no extra charge

What to weigh up

  • The homepage's headline '$150/mo' and '$249/mo' figures don't match either plan you can select on the product pages ($250-$390/mo); they look like an annual-prepay rate quoted in a customer testimonial
  • No LegitScript certification or similar third-party accreditation shown on the site
  • No compounding pharmacy is named anywhere on the site

VyrarX

Readers in a served state who will confirm the medication formulation, dose-specific price and refill cadence before paying.

Reasons to consider it

  • Publishes starting program rates for both molecules
  • Names Locum Tele as its provider network and Rush Pharmacy as its pharmacy
  • Lists the three excluded states in its terms

What to weigh up

  • The public program cards do not identify the medication as compounded or branded; confirm the exact product
  • Higher-dose prices, the shipment supply length and renewal cadence are not published
  • No individual medical director is named

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Freya MedsVyrarX
Normalized Cost/Month
Freya Meds:
53/100
VyrarX:
45/100
Price Transparency
Freya Meds:
94/100
VyrarX:
92/100
Nationwide Access
Freya Meds:
78/100
VyrarX:
78/100
Formulation Options
Freya Meds:
66/100
VyrarX:
66/100
Clinical Oversight
Freya Meds:
71/100
VyrarX:
90/100
Contract Flexibility
Freya Meds:
55/100
VyrarX:
49/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.